Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)

por Vestergaard Kvist, Annika, Faruque, Junaid, Vallejo-Yagüe, Enriqueta, Weiler, Stefan, Winter, Elizabeth M., Burden, Andrea M.
Publicado 2021